OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
Up to CHF 200 MILLION
Exclusive Financial Advisor
Sale to Tandem Diabetes Care, Inc.
January 2023
UNDISCLOSED
Financial Advisor
Acquisition of GlobalMed by Molded Devices, Inc., a Portfolio Company of TruArc Partners
November 2022
$45 Million
Exclusive Financial Advisor
Strategic-Led Equity Financing
August 2022
Up to $475 Million
Financial Advisor
Strategic Alliance / Option-to-Acquire with Abbvie
July 2022
